FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149791683> ?p ?o ?g. }

• W2149791683 endingPage "1863" @default.
• W2149791683 startingPage "1863" @default.
• W2149791683 abstract "<h3>Background</h3> Treatment of latent tuberculosis infection (LTBI) is an important aspect of tuberculosis control in the United States, but the effectiveness of this strategy is compromised by poor adherence to the recommended 9-month isoniazid regimen. In this study, we compared treatment completion and clinically recognized adverse drug reactions in patients prescribed 9 months of isoniazid therapy or 4 months of rifampin therapy for LTBI. <h3>Methods</h3> Retrospective chart review of patients who received LTBI treatment at a public health clinic. <h3>Results</h3> A total of 770 patients were prescribed 9 months of isoniazid therapy, and 1379 patients were prescribed 4 months of rifampin therapy. The percentages of patients who completed 80% or more of their prescribed treatment were 52.6% and 71.6% in the isoniazid and rifampin groups, respectively (<i>P</i><.001). In multivariate logistic regression analysis, treatment regimen was independently associated with treatment completion (adjusted odds ratio for treatment completion, 2.88 for rifampin group vs isoniazid group; 95% confidence interval, 2.27-3.66). Clinically recognized adverse reactions resulting in permanent treatment discontinuation occurred in 4.6% and 1.9% of patients in the isoniazid and rifampin groups, respectively (<i>P</i><.001). Clinically recognized hepatotoxicity was more common in the isoniazid group (1.8%) than in the rifampin group (0.08%,<i>P</i><.001). <h3>Conclusions</h3> Compared with a 9-month isoniazid regimen, a 4-month rifampin regimen was associated with a higher percentage of patients completing treatment and a lower percentage of patients with clinically recognized adverse reactions. Additional studies are warranted to determine efficacy and effectiveness of rifampin therapy for LTBI." @default.
• W2149791683 created "2016-06-24" @default.
• W2149791683 creator A5004770548 @default.
• W2149791683 creator A5008452023 @default.
• W2149791683 creator A5009485509 @default.
• W2149791683 creator A5012638474 @default.
• W2149791683 creator A5028339815 @default.
• W2149791683 creator A5031688558 @default.
• W2149791683 creator A5037593325 @default.
• W2149791683 creator A5044568994 @default.
• W2149791683 creator A5045898489 @default.
• W2149791683 creator A5045977935 @default.
• W2149791683 creator A5049293663 @default.
• W2149791683 creator A5089960831 @default.
• W2149791683 creator A5091131509 @default.
• W2149791683 date "2006-09-25" @default.
• W2149791683 modified "2023-09-26" @default.
• W2149791683 title "Improved Adherence and Less Toxicity With Rifampin vs Isoniazid for Treatment of Latent Tuberculosis" @default.
• W2149791683 cites W1969195096 @default.
• W2149791683 cites W2004753123 @default.
• W2149791683 cites W2012047031 @default.
• W2149791683 cites W2014163375 @default.
• W2149791683 cites W2053626605 @default.
• W2149791683 cites W2064727915 @default.
• W2149791683 cites W2090919994 @default.
• W2149791683 cites W2100015029 @default.
• W2149791683 cites W2118173280 @default.
• W2149791683 cites W2123876596 @default.
• W2149791683 cites W2129481644 @default.
• W2149791683 cites W2130324392 @default.
• W2149791683 cites W2151990581 @default.
• W2149791683 cites W2155353072 @default.
• W2149791683 cites W2200982879 @default.
• W2149791683 cites W574625400 @default.
• W2149791683 cites W80887403 @default.
• W2149791683 cites W116010092 @default.
• W2149791683 doi "https://doi.org/10.1001/archinte.166.17.1863" @default.
• W2149791683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17000943" @default.
• W2149791683 hasPublicationYear "2006" @default.
• W2149791683 type Work @default.
• W2149791683 sameAs 2149791683 @default.
• W2149791683 citedByCount "171" @default.
• W2149791683 countsByYear W21497916832012 @default.
• W2149791683 countsByYear W21497916832013 @default.
• W2149791683 countsByYear W21497916832014 @default.
• W2149791683 countsByYear W21497916832015 @default.
• W2149791683 countsByYear W21497916832016 @default.
• W2149791683 countsByYear W21497916832017 @default.
• W2149791683 countsByYear W21497916832018 @default.
• W2149791683 countsByYear W21497916832019 @default.
• W2149791683 countsByYear W21497916832020 @default.
• W2149791683 countsByYear W21497916832021 @default.
• W2149791683 countsByYear W21497916832022 @default.
• W2149791683 countsByYear W21497916832023 @default.
• W2149791683 crossrefType "journal-article" @default.
• W2149791683 hasAuthorship W2149791683A5004770548 @default.
• W2149791683 hasAuthorship W2149791683A5008452023 @default.
• W2149791683 hasAuthorship W2149791683A5009485509 @default.
• W2149791683 hasAuthorship W2149791683A5012638474 @default.
• W2149791683 hasAuthorship W2149791683A5028339815 @default.
• W2149791683 hasAuthorship W2149791683A5031688558 @default.
• W2149791683 hasAuthorship W2149791683A5037593325 @default.
• W2149791683 hasAuthorship W2149791683A5044568994 @default.
• W2149791683 hasAuthorship W2149791683A5045898489 @default.
• W2149791683 hasAuthorship W2149791683A5045977935 @default.
• W2149791683 hasAuthorship W2149791683A5049293663 @default.
• W2149791683 hasAuthorship W2149791683A5089960831 @default.
• W2149791683 hasAuthorship W2149791683A5091131509 @default.
• W2149791683 hasBestOaLocation W21497916831 @default.
• W2149791683 hasConcept C126322002 @default.
• W2149791683 hasConcept C141071460 @default.
• W2149791683 hasConcept C142724271 @default.
• W2149791683 hasConcept C156957248 @default.
• W2149791683 hasConcept C197934379 @default.
• W2149791683 hasConcept C2776967927 @default.
• W2149791683 hasConcept C2776991065 @default.
• W2149791683 hasConcept C2777975735 @default.
• W2149791683 hasConcept C2778607973 @default.
• W2149791683 hasConcept C2778715236 @default.
• W2149791683 hasConcept C2779806340 @default.
• W2149791683 hasConcept C2781069245 @default.
• W2149791683 hasConcept C2781413609 @default.
• W2149791683 hasConcept C44249647 @default.
• W2149791683 hasConcept C71924100 @default.
• W2149791683 hasConceptScore W2149791683C126322002 @default.
• W2149791683 hasConceptScore W2149791683C141071460 @default.
• W2149791683 hasConceptScore W2149791683C142724271 @default.
• W2149791683 hasConceptScore W2149791683C156957248 @default.
• W2149791683 hasConceptScore W2149791683C197934379 @default.
• W2149791683 hasConceptScore W2149791683C2776967927 @default.
• W2149791683 hasConceptScore W2149791683C2776991065 @default.
• W2149791683 hasConceptScore W2149791683C2777975735 @default.
• W2149791683 hasConceptScore W2149791683C2778607973 @default.
• W2149791683 hasConceptScore W2149791683C2778715236 @default.
• W2149791683 hasConceptScore W2149791683C2779806340 @default.
• W2149791683 hasConceptScore W2149791683C2781069245 @default.
• W2149791683 hasConceptScore W2149791683C2781413609 @default.
• W2149791683 hasConceptScore W2149791683C44249647 @default.

• next